New Zealand markets open in 6 hours 6 minutes
  • NZX 50

    11,552.04
    +156.69 (+1.38%)
     
  • NZD/USD

    0.6232
    +0.0032 (+0.52%)
     
  • ALL ORDS

    7,480.70
    +38.70 (+0.52%)
     
  • OIL

    81.00
    +2.80 (+3.58%)
     
  • GOLD

    1,775.40
    +11.70 (+0.66%)
     

One Integrated Diagnostics Holdings plc (LON:IDHC) insider upped their stake by 0.3% in the previous year

Viewing insider transactions for Integrated Diagnostics Holdings plc's (LON:IDHC ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

View our latest analysis for Integrated Diagnostics Holdings

Integrated Diagnostics Holdings Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Group CEO & Executive Director Hend El Sherbini bought US$455k worth of shares at a price of US$1.00 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$0.76). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Hend El Sherbini was the only individual insider to buy during the last year.

Hend El Sherbini bought a total of 469.88k shares over the year at an average price of US$1.00. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership Of Integrated Diagnostics Holdings

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. Integrated Diagnostics Holdings insiders own about US$117m worth of shares (which is 26% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Do The Integrated Diagnostics Holdings Insider Transactions Indicate?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Integrated Diagnostics Holdings. Nice! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. For instance, we've identified 2 warning signs for Integrated Diagnostics Holdings (1 is a bit unpleasant) you should be aware of.

But note: Integrated Diagnostics Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here